谷氨酰胺在大鼠门静脉高压性胃病中的作用机制

黄湘俊; 王永恒; 段珊珊; 李澜; 孙国辉; 杨媚月; 冷大跃; 张文兴

doi:10.3969/j.issn.1001-5256.2018.05.029

谷氨酰胺在大鼠门静脉高压性胃病中的作用机制

DOI: 10.3969/j.issn.1001-5256.2018.05.029

湖南中医药大学第一附属医院肝胆胰外科

基金项目:

湖南省科技厅项目(2013FJ4058)；湖南省中医药管理局项目(201355)；

详细信息

中图分类号: R573
计量
- 文章访问数: 1848
- HTML全文浏览量: 13
- PDF下载量: 387
- 被引次数: 0
出版历程
- 收稿日期: 2017-11-01
- 出版日期: 2018-05-20

Mechanism of action of glutamine in portal hypertensive gastropathy in rats

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Hunan University of Chinese Medicine

Research funding:

摘要

摘要: 目的初步探讨谷氨酰胺在大鼠门静脉高压性胃病中的作用及相关机制。方法 60只SD大鼠随机均分为4组,A组（假手术）、B组（假手术组+谷氨酰胺）、C组（门静脉部分结扎）、D组（门静脉部分结扎+谷氨酰胺）,每组15只。采用门静脉主干部分结扎法复制大鼠门静脉高压性胃病模型,2周后测量大鼠门静脉压力（PVP）、胃损伤指数（GI）、胃黏膜病理评分（PI）及肝脏形态变化,检测血浆中ALT、AST、Alb、一氧化氮（NO）、TNFα、超氧化物歧化酶（SOD）的表达情况。计量资料2组间比较采用t检验,多组间比较采用方差分析,进一步两两比较采用LSD-t检验。结果 4组间PVP比较差异有统计学差异[（1.17±0.15）k Pa vs（1.21±0.19）k Pa vs（2.65±0.16）k Pa vs（2.18±0.22）k Pa,F=4.60,P<0.05],C组、D组分别与A组、B组比较,差异均有统计学意义（P值均<0.05）;C、D组GI和PI相比差异均有统计学意义[15.52±2.05 vs 8.26±1.23,7.56±1.53 vs 3.15±1.42,t值分别为5.84、7....
- 门静脉高压性胃病 /
- 谷氨酰胺 /
- 大鼠,Sprague-Dawley
Abstract: Objective To investigate the role and mechanism of action of glutamine in portal hypertension gastropathy ( PHG) in rats.Methods A total of 60 Sprague-Dawley rats were randomly divided into groups A ( sham-operation) , B ( sham-operation + glutamine) , C ( partial portal vein ligation) , and D ( partial portal vein ligation + glutamine) . A rat model of PHG was established by partial ligation of the main portal vein. Portal vein pressure ( PVP) , gastric injury index ( GI) , pathological integral ( PI) of the gastric mucosa, and liver morphological changes were measured after 2 weeks, and the plasma levels of alanine aminotransferase ( ALT) , aspartate aminotransferase ( AST) , albumin ( Alb) , nitric oxide ( NO) , tumor necrosis factor-α ( TNFα) , and superoxide dismutase ( SOD) were also measured. The t-test was used for comparison of continuous data between two groups, an analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups. Results There was a significant difference in PVP between groups A, B, C, and D ( 1. 17 ± 0. 15 k Pa vs 1. 21 ± 0. 19 k Pa vs 2. 65 ± 0. 16 k Pa vs 2. 18 ± 0. 22 k Pa, F = 4. 60, P < 0. 05) , and there were also significant differences between groups C/D and groups A/B ( P < 0. 05) . There were significant differences between groups C and D in GI ( 15. 52 ± 2. 05 vs 8. 26 ± 1. 23, t = 5. 84, P < 0. 05) and PI ( 7. 56 ± 1. 53 vs 3. 15 ± 1. 42, t = 7. 45, P < 0. 05) . There were no significant differences in ALT, AST, and Alb between the four groups ( all P > 0. 05) . There were significant differences between the four groups in TNFα ( 0. 56 ± 0. 11 ng/ml vs 0. 41 ± 0. 21 ng/ml vs 1. 35 ± 0. 26 ng/ml vs 0. 68 ± 0. 21 ng/ml, F = 5. 24, P < 0. 05) , NO ( 1. 63 ± 0. 15 μmol/gpro vs 1. 41 ± 0. 12 μmol/gpro vs 5. 52 ± 1. 06 μmol/gpro vs 2. 26 ± 0. 83μmol/gpro, F = 8. 40, P < 0. 05) , and SOD ( 148. 21 ± 6. 21 U/mg vs 154. 21 ± 5. 31 U/mg vs 74. 56 ± 4. 21 U/mg vs 135. 25 ± 4. 82 U/mg, F = 14. 78, P < 0. 05) . There were significant differences in TNFα, NO, and SOD between group C and groups A/B ( all P <0. 05) , as well as between groups C and D ( all P < 0. 05) . Conclusion PHG has various pathogenic factors. Glutamine can alleviate gastric mucosal edema and hemorrhage in rats with PHG and reduce the content of NO, TNFα, and SOD. Glutamine has a good antioxidant effect and thus helps with the treatment of PHG.
- portal hypertensive gastropathy /
- glutamine /
- rats, sprague-dawley

HTML全文

参考文献(18)

[1]SHANG AY, YANG JM, CHEN LP, et al.Changes in gastrointestinal structure and function caused by cirrhotic portal hypertension and related clinical manifestations[J].J Clin Hepatol, 2017, 33 (2) :354-358. (in Chinese) 尚祉胤, 杨敬貌, 陈丽萍, 等.肝硬化门静脉高压导致的胃肠结构和功能改变及其临床表现[J].临床肝胆病杂志, 2017, 33 (2) :354-358.

[2]YANG Z.Current status and perspectives of surgical treatment of portal hypertension[J].J Clin Hepatol, 2016, 32 (2) :250-253. (in Chinese) 杨镇.我国门静脉高压症外科治疗的现况和展望[J].临床肝胆病杂志, 2016, 32 (2) :250-253.

[3]BANG CS, KIM HS, SUK KT, et al.Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis[J].BMC Gastroenterol, 2016, 16 (1) :93.

[4]MASSONI F, RICCI L, PELOSI M, et al.The portal hypertensive gastropathy:a case and review of literature[J].J Clin Diagn Res, 2016, 10 (6) :hd1-hd2.

[5]SEMENOVA TS, PAL'TSEVA EM, ZHIGALOVA SB, et al.Portal hypertensive gastropathy[J].Arkh Patol, 2014, 76 (6) :64-69.

[6]MARQUES C, MAURIZ JL, SIMONETTO D, et al.Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy[J].Ann Hepatol, 2011, 10 (4) :531-539.

[7]ABRALDES JG, PASARIN M, GARCIA-PAGAN JC.Animal models of portal hypertension[J].World J Gastroenterol, 2006, 12 (41) :6577-6584.

[8]VIGNERI S, TERMINI R, PIRAINO A, et al.The stomach in liver cirrhosis.Endoscopic, morphological, and clinical correlations[J].Gastroenterology, 1991, 101 (2) :472-478.

[9]GUTH PH, AURES D, PAULSEN G.Topical aspirin plus HCl gastric lesions in the rat.Cytoprotective effect of prostaglandin, cimetidine, and probanthine[J].Gastroenterology, 1979, 76 (1) :88-93.

[10]MASUDA E, KAWANO S, NAGANO K, et al.Role of endogenous endothelin in pathogenesis of ethanol-induced gastric mucosal injury in rats[J].Am J Physiol, 1993, 265 (3 Pt1) :g474-g481.

[11]SANKAR K, MOORE CM.Transjugular intrahepatic portosystemic shunts[J].JAMA, 2017, 317 (8) :880.

[12]HUNG CR, NEU SL.Acid-induced gastric damage in rats is aggravated by starvation and prevented by several nutrients[J].J Nutr, 1997, 127 (4) :630-636.

[13]TAN S, LI L, CHEN T, et al.β-Arrestin-1 protects against endoplasmic reticulum stress/p53-upregulated modulator of apoptosis-mediated apoptosis via repressing p-p65/inducible nitric oxide synthase in portal hypertensive gastropathy[J].Free Radic Biol Med, 2015, 87:69-83.

[14]LICKS F, HARTMANN RM, MARQUES C, et al.N-acetylcysteine modulates angiogenesis and vasodilation in tomach such as DNA damage in blood of portal hypertensive rats[J].World J Gastroenterol, 2015, 21 (43) :12351-12360.

[15]ABBAS Z, YAKOOB J, USMAN MW, et al.Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL) -8, IL-10, and tumor necrosis factor-alpha levels[J].Saudi J Gastroenterol, 2014, 20 (2) :120-127.

[16]HUANG G, DAI SL, YANG KX, et al.Research advances in portal hypertensive gastropathy[J].J Clin Hepatol, 2016, 32 (2) :358-360. (in Chinese) 黄冠, 戴树龙, 杨坤兴, 等.门静脉高压性胃病的研究进展[J].临床肝胆病杂志, 2016, 32 (2) :358-360.

[17]PRIETO I, JIMENEZ F, ALLER MA, et al.Tumor necrosis factoralpha, interleukin-1beta and nitric oxide:induction of liver megamitochondria in prehepatic portal hypertensive rats[J].World J Surg, 2005, 29 (7) :903-908.

[18]LUO Y, GE L, CHEN HB, et al.Effect of DDC on activity of SOD of bifidobacteria infantis[J].Chin J Immunol, 2016, 32 (8) :1103-1106. (in Chinese) 罗燕, 葛兰, 陈红兵, 等.DDC对婴儿双歧杆菌SOD酶活性的影响[J].中国免疫学杂志, 2016, 32 (8) :1103-1106.

施引文献

资源附件(0)

访问统计